最新ニュース Azenta (NASDAQ:AZTA) 株価情報

Azenta

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

Azenta Inc

Azenta (AZTA) announced the launch of a long-read Whole Genome Sequencing test for clinical applications. Azenta becomes the first commercial provi...

Azenta receives regulatory approval for long-read WGS test

Azenta Non-GAAP EPS of $0.18 beats by $0.07, revenue of $170M beats by $0.17M

Reports Q4 revenue $170M, consensus $169.6M. "We ended FY24 strong, delivering core revenue growth in our Sample Management Solutions and Multiomic...

Azenta reports Q4 non-GAAP EPS 18c, consensus 10c

Sees FY25 adjusted EBITDA margin expansion 300 basis points relative to FY24. Published first on TheFly – the ultimate source for real-time, market...

Azenta sees FY25 total organic revenue up 3%-5% vs. FY24

Azenta ( ($AZTA) ) just unveiled an update. Azenta, Inc. has appointed Lawrence Lin as its new CFO, succeeding Herman Cueto, who will stay on as an...

Azenta Appoints New CFO Amid Revenue Growth

Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript

17:17 EST Flex (FLEX) to replace Azenta (AZTA) in S&P 400 at open on 11/25 Published first on TheFly – the ultimate source for real-time, market-mo...

Flex to replace Azenta in S&P 400 at open on 11/25

Bain Capital is acquiring Envestnet (ENV) in a deal expected to be completed soon, pending final closing conditions. Published first on TheFly – th...

Azenta to replace Envestnet in S&P 600 at open on 11/25

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER AFTER EARNINGS – KORE Group Holdings&nbsp;(KORE)&nbs...

Closing Bell Movers: Keysight up 9% after Q4 earnings beat

Flex set to join S&P midcap 400; Azenta and Concentra Group to join S&P smallcap 600

AVAV

AZEK

AZTA

FLEX

KEYS

KORE

POWL

SGMO

SNEX

SPGI

VREX

WKHS

Press Releases

Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Earnings

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta to Participate in Stephens Annual Investment Conference

Mutual Funds

Markets

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

LVWR

Agilent Technologies

AbCellera Biologics

Avantor

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Cytek Biosciences

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Azenta

ニュース

最新ニュース Azenta (NASDAQ:AZTA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル